| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | TREVENA INC | 38,367 | 242,000 | 0.18% | ||
| 102 | BIOCRYST PHARMACEUTICALS | 84,907 | 241,000 | 0.18% | ||
| 103 | FIVE PRIME THERAPEUTICS INC | 5,837 | 241,000 | 0.18% | ||
| 104 | OPHTHOTECH CORP | 4,702 | 240,000 | 0.18% | ||
| 105 | SANGAMO THERAPEUTICS INCORPORATED | 41,249 | 239,000 | 0.18% | ||
| 106 | ADURO BIOTECH INC | 21,010 | 238,000 | 0.18% | ||
| 107 | LOXO ONCOLOGY INC COM | 10,231 | 237,000 | 0.18% | ||
| 108 | NANTKWEST INC COM | 37,895 | 236,000 | 0.18% | ||
| 109 | CONCERT PHARMACEUTICALS INCORPORATED | 20,939 | 235,000 | 0.17% | ||
| 110 | SERES THERAPEUTICS INC | 8,098 | 235,000 | 0.17% | ||
| 111 | ACCELERON PHARMA INC | 6,910 | 235,000 | 0.17% | ||
| 112 | JUNO THERAPEUTICS INC COM | 6,017 | 231,000 | 0.17% | ||
| 113 | ARROWHEAD PHARMACEUTICALS IN | 43,272 | 230,000 | 0.17% | ||
| 114 | PORTOLA PHARMACEUTICALS INC | 9,735 | 230,000 | 0.17% | ||
| 115 | LA JOLLA PHARMACEUTICAL CO | 14,291 | 229,000 | 0.17% | ||
| 116 | APPLIED GENETIC TECHNOL CORP | 16,223 | 229,000 | 0.17% | ||
| 117 | PUMA BIOTECHNOLOGY | 7,666 | 228,000 | 0.17% | ||
| 118 | ALNYLAM PHARMACEUTICALS INC | 4,078 | 226,000 | 0.17% | ||
| 119 | SORRENTO THERAPEUTICS INC COM NEW | 40,438 | 226,000 | 0.17% | ||
| 120 | EPIZYME INC COM | 21,750 | 223,000 | 0.17% | ||
| 121 | AVEXIS INC COM | 5,869 | 223,000 | 0.17% | ||
| 122 | INOVIO PHARMACEUTICALS INC | 24,058 | 222,000 | 0.16% | ||
| 123 | AMICUS THERAPEUTICS INC COM | 40,705 | 222,000 | 0.16% | ||
| 124 | ZIOPHARM ONCOLOGY INC | 40,175 | 221,000 | 0.16% | ||
| 125 | AKEBIA THERAPEUTICS INC | 29,590 | 221,000 | 0.16% | ||
| 126 | ADAPTIMMUNE THERAPEUTICS PLC | 26,974 | 220,000 | 0.16% | ||
| 127 | CEMPRA INC | 13,284 | 219,000 | 0.16% | ||
| 128 | IMMUNOGEN INC | 70,796 | 218,000 | 0.16% | ||
| 129 | TG THERAPEUTICS INC COM | 35,297 | 214,000 | 0.16% | ||
| 130 | ALDER BIOPHARMACEUTICALS INC | 8,582 | 214,000 | 0.16% | ||
| 131 | AGIOS PHARMACEUTICALS INC | 5,068 | 212,000 | 0.16% | ||
| 132 | AIMMUNE THERAPEUTICS INC COM | 19,501 | 211,000 | 0.16% | ||
| 133 | ACHILLION PHARMACEUTICALS IN | 26,915 | 210,000 | 0.16% | ||
| 134 | KARYOPHARM THERAPEUTICS INC COM | 30,617 | 205,000 | 0.15% | ||
| 135 | ULTRAGENYX PHARMACEUTICAL INC COM | 4,050 | 198,000 | 0.15% | ||
| 136 | UNIQURE NV | 26,511 | 195,000 | 0.14% | ||
| 137 | GLOBAL BLOOD THERAPEUTICS INCORPORATED | 11,710 | 194,000 | 0.14% | ||
| 138 | PROTHENA CORP PLC | 5,509 | 193,000 | 0.14% | ||
| 139 | IMMUNOMEDICS INCORPORATED | 81,010 | 188,000 | 0.14% | ||
| 140 | Esperion Therapeutics Inc | 15,540 | 154,000 | 0.11% | ||
| 141 | NUSTAR ENERGY LP | 3,057 | 152,000 | 0.11% | ||
| 142 | REGULUS THERAPEUTICS INC COM | 46,269 | 134,000 | 0.10% | ||
| 143 | SPECTRA ENERGY PARTNERS LP | 2,788 | 132,000 | 0.10% | ||
| 144 | ONEOK INC NEW | 2,378 | 113,000 | 0.08% | ||
| 145 | UNITED STATES OIL FUND LP | 1,426 | 16,000 | 0.01% | ||
| 146 | STATE STR CORP | 150 | 9,000 | 0.01% | ||
| 147 | STATE STR CORP | 300 | 2,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-020204, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
